Pathway to Prevention of Nosocomial Clostridium difficile Infection (Q38448294)

3 September 2017

Pathway to Prevention of Nosocomial Clostridium difficile Infection (English)

1 reference

3 September 2017

Clostridium difficile

0 references

author

William E Trick

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

9

Donald E Low

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ellie J. C. Goldstein

1

object named as

Ellie J C Goldstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Stuart Johnson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Pierre-Jean Maziade

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Lynne V McFarland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Linda Dresser

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mathieu Millette

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hadi Mazloum

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

English

0 references

publication date

1 May 2015

1 reference

Clinical Infectious Diseases

3 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

60 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

S148-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25922401%20AND%20SRC:MED&resulttype=core&format=json

Detection, treatment, and prevention of Clostridium difficile infection

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Evaluation of hospital complications and costs associated with using ultrasound guidance during abdominal paracentesis procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Recommendations for probiotic use-2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Recommendations for probiotic use in humans-a 2014 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Meta-analysis: probiotics in antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Is primary prevention of Clostridium difficile infection possible with specific probiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clostridium difficile infection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Is high consumption of antibiotics associated with Clostridium difficile polymerase chain reaction-ribotype 027 infections in France?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Small intestinal mucosal toxicity of cis-platinum--comparison of toxicity with platinum analogues and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clinically important interaction between statin drugs and Clostridium difficile toxin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Intestinal colonization and nosocomial spread of Clostridium difficile in pediatric cancer patients under long-term hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Tube feeding, the microbiota, and Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

How effective are the usual treatments for Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clostridium difficile: preventing epidemic outbreaks in home health

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clostridium difficile-associated enteric disease after percutaneous endoscopic gastrostomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

A meta-analysis of probiotic efficacy for gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults--a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Measures to control and prevent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clostridium difficile infection in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Tests for the diagnosis of Clostridium difficile infection: the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Clinical recognition and diagnosis of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Pathology consultation on detection of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

C. difficile infection (CDI) in a long-term acute care facility (LTAC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Certification in infection control matters: Impact of infection control department characteristics and policies on rates of multidrug-resistant infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Bacterial contamination of uniforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

A case-control study of community-associated Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142

Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV142